Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Radiation Oncology
•
Thoracic Malignancies
What would be your post-operative therapy approach for a high grade neuroendocrine carcinoma of the thymus?
What if there was mediastinal nodal involvement?
Answer from: Radiation Oncologist at Academic Institution
Postoperative RT.
Sign in or Register to read more
13071
Related Questions
How would you treat a locally recurrent NSCLC abutting the heart that was previously treated with conventional chemoRT?
What is the role for molecular agents alone for medically inoperable NSCLC who is not a good candidate for chemoRT?
Would you offer definitive chemoRT for NSCLC with histologically-proven contralateral station 11 nodal involvement?
How do manage stage III resectable NSCLC patients treated with neoadjuvant chemoimmunotherapy per CheckMate 816 with residual disease who subsequently refuse surgery?
What dose/fractionation would you use to treat an oligometastatic AP window lymph node?
Do you offer adjuvant osimertinib to EGFR exon 19 deleted patients with T2N0 NSCLC treated with definitive SBRT?
How would you approach a localized but unresectable adenoid cystic carcinoma of the distal trachea?
How would you manage adjuvant therapy for a patient with pulmonary adenoid cystic carcinoma s/p resection with positive bronchial and vascular margins and nodal involvement?
Should we repeat a dose-escalation trial for stage III NSCLC in the era of modern radiotherapy techniques and dose constraints?
What are your top takeaways in Thoracic Cancers from ASCO 2023?